Tuberculosis extremadamente resistente (TB-XDR), historia y situación actual

Tuberculosis extremadamente resistente (TB-XDR), historia y situación actual

Las enfermedades ocasionadas por micobacterias constituyen sin duda un capítulo importante de la patología infecciosa en la historia de la humanidad encontrándose desde sus albores enfermedades tan antiguas como la tuberculosis y la lepra, así como otras las producidas por otras micobacterias. La t...

Full description

Bibliographic Details
Main Authors:	Alberto Mendoza Ticona, Eduardo Gotuzzo Herencia
Format:	Article
Language:	English
Published:	Colegio Médico del Perú 2018-06-01
Series:	Acta Médica Peruana
Subjects:	tuberculosis Mycobacteria Tuberculosis TB-XDR
Online Access:	https://amp.cmp.org.pe/index.php/AMP/article/view/2644

Similar Items

Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report
by: Nafiseh Izadi, et al.
Published: (2015-01-01)

Beijing Lineage of MDR Mycobacterium tuberculosis in Bulgaria, 2007–2011
by: Stefan Panaiotov, et al.
Published: (2014-11-01)

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019
by: Yousra Kherabi, et al.
Published: (2022-09-01)

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
by: Ketaki V Utpat, et al.
Published: (2023-01-01)

Pre-XDR spinal tuberculosis and 360° approach in two surgical times: a case report
by: C. Montero-Silva, et al.
Published: (2023-01-01)

Situación de la tuberculosis en el Perú
by: Cesar Bonilla Asalde
Published: (2020-08-01)

Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01)

Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases
by: Isaac Darko Otchere, et al.
Published: (2023-01-01)

Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review
by: Varshney K, et al.
Published: (2021-12-01)

XDR-TB Transmitted from Mother to 10-Month-Old Infant: Diagnostic and Therapeutic Problems
by: Monika Kozińska, et al.
Published: (2022-02-01)

Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
by: James Millard, et al.
Published: (2023-05-01)

Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94–32 central Asian/Russian clusters
by: B. J. Klotoe, et al.
Published: (2019-06-01)

The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
by: Heidary M, et al.
Published: (2019-11-01)

Turning the tide against tuberculosis
by: Nesri Padayatchi, et al.
Published: (2017-03-01)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
by: Gunar Günther, et al.
Published: (2015-03-01)

Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection
by: Max R. O’Donnell, et al.
Published: (2013-03-01)

Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
by: Roshni Mary Prince, et al.
Published: (2023-08-01)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of <i>Mycobacterium tuberculosis</i>
by: María Alejandrina Martínez-González, et al.
Published: (2021-12-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01)

Extensively Drug-Resistant Tuberculosis, Pakistan
by: Rumina Hasan, et al.
Published: (2010-09-01)

Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa
by: Charlotte L. Kvasnovsky, et al.
Published: (2016-09-01)

Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012–2016
by: Imen Bouzouita, et al.
Published: (2019-03-01)

Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis
by: Giovanni Sotgiu, et al.
Published: (2013-01-01)

Investigation of Susceptibility of Mycobacterium tuberculosis Complex Strains Isolated from Clinical Samples Against the First and Second-Line Anti-tuberculosis Drugs by the Sensititre MycoTB Plate Method
by: Figen KAYSERİLİ ORHAN, et al.
Published: (2018-03-01)

Extensively drug-resistant tuberculosis: a case report and literature review
by: João Alves de Araújo-Filho, et al.

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
by: Benoît Henry, et al.
Published: (2016-03-01)

Trends in multidrug-resistant tuberculosis
by: I. M. F. Dias-Baptista, et al.
Published: (2008-01-01)

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
by: Hoa Binh Nguyen, et al.
Published: (2016-06-01)

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
by: Jay Achar, et al.
Published: (2017-10-01)

Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
by: Mahdieh Sayadi, et al.
Published: (2020-06-01)

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011– 2016
by: Cannas A, et al.
Published: (2019-10-01)

Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
by: Marie Jaspard, et al.
Published: (2020-08-01)

Global trends in the incidence rates of MDR and XDR tuberculosis: Findings from the global burden of disease study 2019
by: Qingting Bu, et al.
Published: (2023-02-01)

Tailored treatment for tuberculosis in transgender individuals: a call for a patient-centered approach from a large Italian cohort
by: Niccolò Riccardi, et al.
Published: (2024-01-01)

Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients
by: Fahmida Rahman, et al.
Published: (2013-01-01)

RepTB: a gene ontology based drug repurposing approach for tuberculosis
by: Anurag Passi, et al.
Published: (2018-05-01)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
by: Barbara Eker, et al.
Published: (2008-11-01)

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
by: Pravin K. Singh, et al.
Published: (2019-09-01)

Extensively Drug-Resistant Tuberculosis, Central China, 2007–2009
by: Dawei Shi, et al.
Published: (2012-11-01)